Is Pliant Therapeutics, Inc. overvalued?

Pliant Therapeutics, Inc. (PLRX) — key valuation metrics and fundamentals.

No verdict

Price

$1.07

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$66.3M

Dividend yield

0.0%

Return on equity

-59.1%

Sector

Healthcare

Fair value compares PLRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks